India’s first COVID-19 vaccine ‘COVAXIN’ by Bharat Biotech gets DCGI approval for human trials

COVAXIN, India’s first vaccine candidate against novel coronavirus, developed by vaccine maker Bharat Biotech gets the approval of DCGI for Phase I and II clinical trials.


Share this post

Share on facebook
Share on google
Share on twitter
Share on linkedin
Share on pinterest
Share on print
Share on email